Variable | HR | 95% CI | p Value* |
---|---|---|---|
Gender | |||
Male | 1 | ||
Female | 0.614 | 0.263 to 1.433 | 0.259 |
Age | |||
<65 | 1 | ||
≥65 | 1.009 | 0.974 to 1.046 | 0.603 |
Tumour location | |||
Right side | 1 | ||
Left side | 0.622 | 0.279 to 1.390 | 0.247 |
Histological differentiation | |||
Well | 1 | ||
Moderate | 2.19 | 0.338 to 14.191 | 0.411 |
Poor and Mucinous | 0.909 | 0.117 to 7.085 | 0.927 |
TNM stage | |||
I | 1 | ||
IIA | 1.246 | 0.768 to 1.587 | 0.163 |
IIB | 2.431 | 0.862 to 2.982 | 0.331 |
Lymphovascular invasion | |||
No | 1 | ||
Yes | 3.398 | 0.453 to 25.497 | 0.234 |
Number of retrieved lymph nodes | |||
<12 | 1 | ||
≥12 | 0.955 | 0.907 to 1.006 | 0.085 |
Serum CEA | |||
<5 | 1 | ||
≥5 | 4.516 | 1.975 to 10.330 | <0.001 |
CXCR3 | |||
High expression | 1 | ||
Low expression | 1.1 | 0.422 to 2.869 | 0.845 |
CXCR4 | |||
High expression | 1 | ||
Low expression | 0.813 | 0.362 to 1.830 | 0.618 |
*p<0.1 indicates statistical significance.
CEA, carcinoembryonic antigen; TNM, tumour, node, metastases.